Tag: use

TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, announces that it is proposing to arrange a private placement offering of up to 30,952,381 units, at a price of $0.021 per unit, for gross proceeds to Revive of up to $650,000, and to settle $67,400 owing pursuant to an arm’s length note payable by the issuance of 3,209,523 units, at a price of $0.021 per unit, being the same issue price and security being offering pursuant to the private placement.

The deal is Fluence’s largest ever project transaction globally and one of the largest energy storage transactions by MWh in the Australian National Energy Market (NEM) to date, marking 5 GWh of projects by Fluence in Australia

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Wells Fargo (NYSE: WFC) To Contact Him Directly To Discuss Their Options

Traditional meets decentralized finance in our next-generation, 3-factor authentication digital identity solution. Powered by Verifiable Credentials, authenticated biometrics, and real-time database validation, this innovation provides the assurance needed for safe international asset transactions, and truly establishes seamless and secure cross-border asset flows.